Robert William Sidwell
#136,072
Most Influential Person Now
Robert William Sidwell's AcademicInfluence.com Rankings
Robert William Sidwellbiology Degrees
Biology
#9343
World Rank
#12538
Historical Rank
Neuroscience
#1358
World Rank
#1404
Historical Rank

Download Badge
Biology
Robert William Sidwell's Degrees
- PhD Neuroscience Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Robert William Sidwell Influential?
(Suggest an Edit or Addition)Robert William Sidwell's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring (2003) (955)
- Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide (1972) (954)
- Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. (1973) (468)
- Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. (1972) (410)
- Handbook of Animal Models of Infection (1999) (347)
- Prenatal Viral Infection Leads to Pyramidal Cell Atrophy and Macrocephaly in Adulthood: Implications for Genesis of Autism and Schizophrenia (2002) (262)
- Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice (1999) (258)
- Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection (1998) (250)
- Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection (2006) (225)
- Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice (2006) (209)
- Influenza virus resistance to neuraminidase inhibitors. (1998) (208)
- Antiviral activities of biflavonoids. (1999) (194)
- Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. (2003) (180)
- Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. (1998) (172)
- Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities (2001) (169)
- Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071 (1998) (166)
- Identification of active antiviral compounds against a New York isolate of West Nile virus. (2002) (163)
- Synthesis and antiviral activity of certain thiazole C-nucleosides. (1977) (162)
- In Vitro Effect of 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxyribonucleic Acid and Ribonucleic Acid Viruses (1973) (159)
- Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice (2006) (150)
- Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. (1992) (148)
- Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. (1991) (145)
- TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection1 (2006) (140)
- Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N4-Hydroxycytidine (2004) (132)
- Demystifying the cost barriers to offsite construction in the UK (2011) (128)
- Use of disposable micro tissue culture plates for antiviral and interferon induction studies. (1971) (126)
- Ribavirin: an antiviral agent. (1979) (125)
- Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS. (2006) (124)
- Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses (2002) (123)
- Effect of Interferon-Alpha and Interferon-Inducers on West Nile Virus in Mouse and Hamster Animal Models (2004) (122)
- In vitro and in vivo assay systems for study of influenza virus inhibitors. (2000) (120)
- In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections (2007) (119)
- In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. (2007) (117)
- TLR3 Is Essential for the Induction of Protective Immunity against Punta Toro Virus Infection by the Double-Stranded RNA (dsRNA), Poly(I:C12U), but not Poly(I:C): Differential Recognition of Synthetic dsRNA Molecules1 (2007) (115)
- In vitro and in vivo influenza virus-inhibitory effects of viramidine. (2005) (113)
- Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice (2002) (107)
- Prenatal viral infection causes alterations in nNOS expression in developing mouse brains (2000) (107)
- A review of compounds exhibiting anti-orthopoxvirus activity in animal models (2003) (106)
- In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201 (2001) (98)
- Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin (2006) (96)
- Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza (2002) (95)
- In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice (1991) (92)
- Treatment of Lethal Vaccinia Virus Respiratory Infections in Mice with Cidofovir (2001) (90)
- Error-prone replication of West Nile virus caused by ribavirin. (2005) (85)
- Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. (2001) (82)
- Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. (2002) (82)
- In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. (1968) (81)
- Quantitative Studies on Fabrics as Disseminators of Viruses (1970) (73)
- Heterocyclic Thiosemicarbazones: Correlation Between Structure, Inhibition of Ribonucleotide Reductase, and Inhibition of DNA Viruses 1 (1970) (72)
- Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. (2000) (70)
- Respiratory syncytial virus infections: recent prospects for control. (2006) (69)
- Activities of Oseltamivir and Ribavirin Used Alone and in Combination against Infections in Mice with Recent Isolates of Influenza a (H1N1) and B Viruses (2006) (69)
- Effect of 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Herpes and Vaccinia Keratitis and Encephalitis in Laboratory Animals (1973) (69)
- Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. (1997) (68)
- Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides. (1973) (68)
- The role of cerebellar genes in pathology of autism and schizophrenia (2008) (68)
- Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. (2001) (63)
- Neutralizing Viruses in Suspensions by Copper Oxide-Based Filters (2007) (63)
- Suppression by 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) of Influenza Virus-Induced Infections in Mice (1973) (60)
- In vitro and in vivo Phlebovirus inhibition by ribavirin (1988) (57)
- Combination Treatment of Influenza A Virus Infections in Cell Culture and in Mice with the Cyclopentane Neuraminidase Inhibitor RWJ-270201 and Ribavirin (2002) (57)
- Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. (2007) (56)
- Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity (1982) (56)
- Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid. (1993) (53)
- Quantitative studies on fabrics as disseminators of viruses. II. Persistence of poliomyelitis virus on cotton and wool fabrics. (1966) (53)
- STUDIES OF LATENT Q FEVER INFECTIONS. II. EFFECTS OF MULTIPLE CORTISONE INJECTIONS. (1964) (53)
- Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives. (1995) (52)
- Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. (2004) (50)
- In Vitro Activity of Expanded-Spectrum Pyridazinyl Oxime Ethers Related to Pirodavir: Novel Capsid-Binding Inhibitors with Potent Antipicornavirus Activity (2004) (50)
- Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine (1992) (50)
- Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice (1992) (48)
- Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero (1998) (48)
- Mutations in the E9L Polymerase Gene of Cidofovir-Resistant Vaccinia Virus Strain WR Are Associated with the Drug Resistance Phenotype (2006) (48)
- Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice (1998) (47)
- Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. (1994) (46)
- STUDIES ON LATENT Q FEVER INFECTIONS. I. EFFECTS OF WHOLE BODY X-IRRADIATION UPON LATENTLY INFECTED GUINEA PIGS, WHITE MICE AND DEER MICE. (1964) (46)
- Antiviral Activity of Nucleoside Analogues against SARS-coronavirus (SARS-CoV) (2006) (45)
- Azapurine nucleosides. 2. Synthesis and antiviral activity of 7-amino-3- -D-arabinofuranosyl-v-triazolo (4,5-d)pyrimidine and related nucleosides. (1972) (45)
- Modeling hamsters for evaluating West Nile virus therapies. (2004) (44)
- Antiviral Activity of 3-Deazaguanine, 3-Deazaguanosine, and 3-Deazaguanylic Acid (1977) (44)
- Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. (2002) (44)
- Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice (1996) (43)
- Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. (2007) (42)
- An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus. (2003) (42)
- Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine. (1973) (41)
- Activity of T-1106 in a Hamster Model of Yellow Fever Virus Infection (2007) (40)
- Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303. (1993) (40)
- Antiviral mechanisms of action. (1980) (40)
- Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin (2008) (39)
- Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero (2004) (39)
- Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival. (2005) (38)
- Treatment of Cowpox Virus Respiratory Infections in Mice with Ribavirin as a Single Agent or Followed Sequentially by Cidofovir (2000) (38)
- Interferon Alfacon-1 Protects Hamsters from Lethal Pichinde Virus Infection (2005) (37)
- Pharmacodynamic Evaluation of RWJ-270201, a Novel Neuraminidase Inhibitor, in a Lethal Murine Model of Influenza Predicts Efficacy for Once-Daily Dosing (2001) (37)
- Effect of selenazofurin on influenza A and B virus infections of mice. (1986) (37)
- Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. (2003) (36)
- Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. (2000) (36)
- Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). (1978) (36)
- Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. (2004) (35)
- Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. (1993) (35)
- Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters. (1968) (35)
- Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections. (1988) (34)
- Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. (1995) (34)
- Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles. (1976) (33)
- Antiviral Activity of Naturally Occurring Anthraquinones and Anthraquinone Derivatives (1990) (33)
- Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid. (1994) (33)
- Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. (1991) (33)
- Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice. (2007) (32)
- Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances (1981) (32)
- West Nile virus infection of the placenta. (2006) (32)
- Effect of l-β-D-Ribofuranosyl-l,2,4-Triazole-3-Carboxamide (Ribavirin) on Friend Leukemia Virus Infections in Mice (1975) (31)
- Quantitative studies on fabrics as disseminators of viruses. 3. Persistence of vaccinia virus on fabrics impregnated with a virucidal agent. (1967) (31)
- Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. (2008) (30)
- Inhibition of Measles Virus Replication by 5′-Nor Carbocyclic Adenosine Analogues (2001) (30)
- Purine Analogs as Potential Anticytomegalovirus Agents∗ (1969) (29)
- Coumarins and Pyranocoumarins, Potential Novel Pharmacophores for Inhibition of Measles Virus Replication (2002) (29)
- Comparative Study of the Anti-Human Cytomegalovirus Activities and Toxicities of a Tetrahydrofuran Phosphonate Analogue of Guanosine and Cidofovir (1999) (28)
- Inhibition of RNA Virus Replication in Vitro by 3-Deazacytidine and 3-Deazauridine (1972) (28)
- In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. (1995) (28)
- Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes. (2006) (28)
- Recombinant Eimeria Protozoan Protein Elicits Resistance to Acute Phlebovirus Infection in Mice but Not Hamsters (2006) (27)
- Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus. (2007) (27)
- Efficacy of 9-β-d-Arabinofuranosylhypoxanthine 5′-Monophosphate in Therapy of Equine Abortion Virus-Induced Hepatitis in Hamsters (1975) (27)
- Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors. (1978) (26)
- Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice (1991) (26)
- In vitro and in vivo Effect of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) on Types 1 and 3 Para-influenza Virus Infections (1975) (26)
- Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201. (2001) (26)
- in vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring system. (2002) (25)
- Potential Role of Immunomodulators for Treatment of Phlebovirus Infections of Animals a (1992) (25)
- 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection. (1999) (25)
- Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug. (2002) (25)
- In vivo anti-influenza virus activity of a zinc finger peptide (1997) (24)
- Characterization and Treatment of Cidofovir-Resistant Vaccinia (WR Strain) Virus Infections in Cell Culture and in Mice (2005) (23)
- Target-Organ Treatment of Neurotropic Virus Diseases: Efficacy as a Chemotherapy Tool and Comparison of Activity of Adenine Arabinoside, Cytosine Arabinoside, Idoxuridine, and Trifluorothymidine (1972) (23)
- Anti-Influenza Virus Activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its Derivatives (2006) (23)
- Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. (1998) (23)
- Quantitative studies on fabrics as disseminators of viruses. V. Effect of laundering on poliovirus-contaminated fabrics. (1971) (23)
- Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters (2006) (23)
- EFFECT OF RIBAVIRIN ON VIRAL HEPATITIS IN LABORATORY ANIMALS (1977) (22)
- Activity of selenazofurin against influenza A and B viruses in vitro (1985) (22)
- Studies of latent Q fever infections. 3. Effects of parturition upon latently infected guinea pigs and white mice. (1966) (22)
- Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine. (1975) (21)
- Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201. (2001) (21)
- Effects of Zidovudine on Friend Virus Complex Infection in Rfv‐3r/s Genotype‐Containing Mice Used as a Model for HIV Infection (1990) (21)
- RESULTS OF A FIVE-YEAR SURVEY FOR CERTAIN ENZOOTIC DISEASES IN THE FAUNA OF WESTERN UTAH. (1965) (21)
- Bioassay system for determining ribavirin levels in human serum and urine. (1981) (21)
- Quantitative Studies on Fabrics as Disseminators of Viruses (1970) (21)
- Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice. (2007) (20)
- Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. (1999) (20)
- Effect of Oral Gavage Treatment with ZnAL42 and other Metallo-Ion Formulations on Influenza a H5N1 and H1N1 Virus Infections in Mice (2007) (20)
- Tularemia in the Wildlife and Livestock of the Great Salt Lake Desert Region, 1951, through 1964. (1965) (20)
- BRUCELLOSIS IN WILDLIFE AND LIVESTOCK OF WEST CENTRAL UTAH. (1965) (20)
- Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812). (2003) (20)
- Broad-spectrum inhibitor of viruses in the Flaviviridae family. (2005) (19)
- Determination of antiviral activity (1986) (19)
- Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice (2003) (19)
- Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity. (2004) (19)
- Synthesis and antitumor antiviral activities of 1-.beta.-D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates (1972) (19)
- The Mouse Model of Influenza Virus Infection (1999) (18)
- Influence of Malnutrition and Alterations in Dietary Protein on Murine Rotaviral Disease 1 (1983) (18)
- Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog. (1995) (17)
- Potentially infectious agents associated with shearling bedpads. I. Effect of laundering with detergent-disinfectant combinations on polio and vaccinia viruses. (1970) (17)
- Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine. (1993) (17)
- Anti‐cowpox Virus Activities of Certain Adenosine Analogs, Arabinofuranosyl Nucleosides, and 2′‐Fluoro‐arabinofuranosyl Nucleosides (2004) (17)
- Viral Keratitis-Inhibitory Effect of 9-β-d-Arabinofuranosylhypoxanthine 5′-Monophosphate (1975) (17)
- Treatment of Mannan-Enhanced Influenza B Virus Infections in Mice with Oseltamivir, Ribavirin and Viramidine (2004) (17)
- Experimental studies with four species of Brucella in selected wildlife, laboratory, and domestic animals. (1967) (16)
- HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice. (1992) (16)
- Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections. (1990) (16)
- Enhancement of Interferon Antiviral Action in L-Cells by Cyclic Nucleotides (1974) (16)
- Influence of Treatment Schedule and Viral Challenge Dose on the in Vivo Influenza Virus-Inhibitory Effects of the Orally Administered Neuraminidase Inhibitor GS 4104 (1999) (16)
- Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? (2008) (15)
- Synthesis and biological activity of 9-beta-D-arabinofuranosyladenine cyclic 3',5'-phosphate and 9-beta-D-arabinofuranosylguanine cyclic 3',5'-phosphate. (1974) (15)
- Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells (1996) (15)
- In vitro effect of a variety of biologically active compounds on human cytomegalovirus. (1972) (15)
- GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitro (1997) (15)
- Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice. (1996) (15)
- Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment. (1991) (14)
- Experimental disease models of influenza virus infections: recent developments (2004) (14)
- Failure of 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) to Stimulate Interferon (1973) (14)
- Effect of Triacontanol on Numbers and Functions of Cells Involved in Inflammatory Responses (1992) (14)
- Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A) (1987) (14)
- A NEW CLASS OF POTENT GUANINE ANTIMETABOLITES, SYNTHESIS OF 3-DEAZAGUANINE, 3-DEAZAGUANOSINE, AND 3-DEAZAGUANYLIC ACID BY A NOVEL RING CLOSURE OF IMIDAZOLE PRECURSORS (1975) (14)
- SYNTHESIS AND ANTIVIRAL ACTIVITY OF SOME PHOSPHATES OF THE BROAD-SPECTRUM ANTIVIRAL NUCLEOSIDE, 1-β-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE (RIBAVIRIN) (1978) (14)
- Synthesis and biological activity of certain carbamoyl and alkoxycarbonyl derivatives of adenosine 3',5'-cyclic phosphate. (1973) (14)
- Effect of human, recombinant interleukin 2 on Punta Toro virus infections in C57BL/6 mice. (1991) (14)
- Epidemiological aspects of venezuelan equine encephalitis virus infections. (1967) (13)
- Structure-Activity Relationship of Phosphonic Acid Analogs of Acyclovir or Ganciclovir Against Human Cytomegalovirus in MRC-5 Cells (1994) (13)
- Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitro. (1991) (13)
- Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus. (1995) (13)
- Q fever antibody response in experimentally infected wild rodents and laboratory animals. (1962) (12)
- A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues. (1988) (12)
- IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA. (1965) (12)
- Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses. (1994) (12)
- Spectrum of Virus Inhibition by Consensus Interferon YM643 (2000) (12)
- COMPARISON OF THE ANTICYTOMEGALOVIRUS ACTIVITY OF A GROUP OF PYRIMIDINE ANALOGS * (1970) (12)
- THE OCCURRENCE OF A POSSIBLE EPIZOOTIC OF Q FEVER IN FAUNA OF THE GREAT SALT LAKE DESERT OF UTAH. (1964) (12)
- Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1. (2008) (11)
- Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection. (1991) (11)
- EFFECT OF RIBAVIRIN ON TYPE 2 HERPESVIRUS HOMINIS (HVH/2) IN VITRO AND IN VIVO (1977) (11)
- Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice. (1976) (10)
- Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice. (1991) (10)
- Effects of Folic Acid Malnutrition on Rotaviral Infection in Mice 1 (1984) (10)
- Synthesis and antiviral activity of 4'-hydroxy-5,6,7,8-tetramethoxyflavone. (1972) (10)
- Synthesis and antitumor and antiviral activities of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-iminopyrimidine and its derivatives. (1979) (10)
- TLR 3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection 1 (2006) (9)
- DNA virus inhibitory activity of 1- -D-arabinofuranosylcytosine-3',5'-cyclic phosphate. (1973) (9)
- In vitro studies on the antiviral activity of 1, 3-bis(2-chloroethyl)-1-nitrosourea. (1966) (9)
- Procedure for the evaluation of the virucidal effectiveness of an ethylene oxide gas sterilizer. (1969) (9)
- Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. (1993) (9)
- Effects of a series of purine analogs on Friend leukemia virus infections in mice. (1968) (9)
- Effect of phosphonic acidanalogs of acyclovir and ganciclovir on in vitro cytomegalovirus infections (1989) (9)
- Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection. (2007) (8)
- Role of virucides in controlling virus dissemination by fabrics (1969) (8)
- Selective cytotoxicity towards cytomegalovirus-infected cells by immunotoxins consisting of gelonin linked to anti-cytomegalovirus antibody. (1995) (8)
- Potent in vitro Activity of the Albumin Fusion Type 1 Interferons (Albumin-Interferon-Alpha and Albumin-Interferon-Beta) against RNA Viral Agents of Bioterrorism and the Severe Acute Respiratory Syndrome (SARS) Virus (2008) (8)
- COMPARISON OF THE DEVELOPMENT OF RESISTANT STRAINS OF TYPE 1 HERPES SIMPLEX VIRUS TO IN VITRO ANTIVIRAL ACTIVITY OF 5‐IODO‐2‐ DEOXYURIDINE OR RIBAVIRIN. (1977) (8)
- Inhibition of Experimental Deoxyribonucleic Acid Virus-Induced Encephalitis by 9-β-d-Arabinofuranosylhypoxanthine 5′-Monophosphate (1975) (7)
- Synthesis and anti-DNA -virus activity of the 5'-monophosphate and the cyclic 3',5'-monophosphate of 9-(beta-D-xylofuranosyl) guanine. (1976) (7)
- Utilization of Alpha-1-Acid Glycoprotein Levels in the Serum as a Parameter for in Vivo Assay of Influenza Virus Inhibitors (2001) (7)
- PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with Down syndrome. (1987) (7)
- Synthesis of Acyclonucleoside Phosphonates as Antiviral Agents Against Cytomegalovirus (1994) (7)
- In Vitro and in Vivo Phlebovirus Inhibition by Nucleosides Related to Ribavirin (1989) (7)
- Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st Edition) (2006) (7)
- Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator. (1992) (6)
- Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice. (1995) (6)
- In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections. (1975) (6)
- Synthesis of Phosphonic Acid Analogs of Acyclovir (ACV) and Canciclovir (DHPG) (1989) (6)
- Synthesis and anti-deoxyribonucleic acid virus activity of certain 9-beta-D-arabinofuranosyl-2-substituted adenine derivatives. (1974) (6)
- Lack of suppression of resistance factors to influenza infections in mice pretreated with virazole. (1977) (6)
- Herpes simplex keratitis in hamsters as a system for evaluating potential antiviral agents. (1966) (6)
- Synthesis of Acyclonucleoside Phosphonates for Evaluation as Antiviral Agents (1991) (6)
- In Vitro Antiviral Activity of 6-Substituted 9-β-d-Ribofuranosylpurine 3′,5′-Cyclic Phosphates (1974) (6)
- Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice. (2001) (6)
- Bovine leukemia virus inhibition in vitro by ribavirin (1981) (5)
- Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections. (1996) (5)
- Overview of viral agents in pediatric enteric infections (1986) (5)
- Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice. (1992) (5)
- SYNTHESIS AND ANTIVIRAL AND ANTIMICROBIAL ACTIVITY OF CERTAIN 1-β-D-RIBOFURANOSYL-4,5-DISUBSTITUTED IMIDAZOLES (1976) (5)
- Potentially Infectious Agents Associated with Shearling Bedpads (1970) (5)
- Inhibition of reoviruses in vitro by selected antiviral substances (1981) (5)
- Chapter 15. Antiviral Agents (1981) (5)
- Effect of Host Weight Loss on Friend Leukemia Virus Infections in Swiss, DBA/2, and BALB/c Mice.∗ (1965) (5)
- Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides (1973) (5)
- Murine cytomegalovirus-inhibitory effects of ImuVert. (1993) (5)
- Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice. (1968) (4)
- Arbovirus Complement Fixing Antibodies in Sera of Wildlife of West Central Utah ∗ (1965) (4)
- Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice. (1994) (4)
- Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes. (1995) (4)
- Effect of oxamisole on immune parameters of mice infected with murine hepatitis. (1990) (4)
- In vitro Inhibition of the Measles Virus by Novel Ring‐Expanded (“Fat”) Nucleoside Analogues Containing the Imidazo[4,5‐e][1,3]diazepine Ring System. (2003) (4)
- Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T). (1992) (4)
- Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice. (1995) (4)
- In Vivo Antiviral Properties of Biologically Active Compounds (1968) (3)
- SUSCEPTIBILITY OF WILD RODENTS TO EXPERIMENTAL INFECTION WITH COXIELLA BURNETII. (1963) (3)
- Epidemiological Aspects of Venezuelan Equine Encephalitis Virus Infections (1967) (3)
- Effect of Imexon on Friend Virus Complex Infection in Rfv‐3r/s Genotype‐Containing Mice as a Model for AIDS a (1990) (3)
- Development of antiviral levels of ribavirin in serum and urine of orally treated rats. (1981) (3)
- A consideration of animal models used for study of influenza virus inhibitors (2001) (3)
- Development of Friend leukemia virus in spleen and plasma of Swiss mice. (1965) (3)
- Animal Models for HBV Infections — Transgenic Mice (1999) (3)
- Effect of immunomodulators in the hu-PBL-SCID mouse model. (1991) (3)
- Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice. (1975) (2)
- Effect of vidarabine in dimethyl sulfoxide vehicle on type 1 herpesvirus-induced cutaneous lesions in laboratory animals. (1987) (2)
- Test Systems for Evaluating the Antiviral Activity of Nucleoside Analogues (1979) (2)
- Models of antiviral resistance. (1995) (2)
- Antiviral and Immunoenhancing Properties of 7-Thia-8-Oxoguanosine and Related Guanosine Analogues (1992) (2)
- STUDIES ON INFECTIOUS DISEASES IN WILD ANIMALS IN UTAH. V. EXPERIMENTAL ROCKY MOUNTAIN SPOTTED FEVER IN THE COYOTE, CANIS LATRANS LESTES MERRIAM. (1963) (2)
- SYNTHESIS AND ANTITUMOR AND ANTIVIRAL ACTIVITIES OF 1-β-D-ARABINOFURANOSYL-2-AMINO-1,4(2H)-IMINOPYRIMIDINE, AND ITS DERIVATIVES (1979) (2)
- Virus Infection by the Double-Stranded RNA Protective Immunity against Punta Toro TLR 3 Is Essential for the Induction of (2007) (2)
- 5-membered azaheterocycles and their nucleosides. (1980) (2)
- The Potential of Nucleosides as Antiviral Agents (1976) (2)
- Viral Infection and Abnormal Brain Development: A DNA Microarray Study (2007) (1)
- Efficacy of 5-Halogenated 2′-Deoxyuridines on Vaccinia Virus Thymidine Kinase Positive and Negative Strains, and Influence of Cell Type on Antiviral Potency (2007) (1)
- In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice (1991) (1)
- Twocellblockage of FVB/N embryo development: An artifact of cell culture (1991) (1)
- SYNTHESIS AND ANTI-DEOXYRIBONUCLEIC ACID VIRUS ACTIVITY OF CERTAIN 9-BETA-D-ARABINOFURANOSYL-2-SUBSTITUTED ADENINE DERIVATIVES (1974) (1)
- Experiences with biological response modifiers in animal models for AIDS (1992) (1)
- Anti-respiratory syncytial virus activity of selected polyoxometalates (1995) (1)
- Guinea Pig Antibody Response Following A Secondary Injection of Coxiella burnetti (1967) (1)
- SYNTHESIS AND ANTIVIRAL ACTIVITY OF CERTAIN THIAZOLE C-NUCLEOSIDES (1977) (1)
- The Potential Role of Cytokines in the Treatment of Viral Infections (2012) (1)
- New Ribonucleosides with Surrogate Bases: Synthesis, Enzymology, Molecular Docking Studies and Antiviral Activity (2007) (1)
- Effect of the combination of human recombinant alpha interferon-A/D and 2',3'-didehydro=2',3'-dideoxythymidine on murine retrovirus disease (1994) (1)
- Selective inhibition ofcytomegaloviruses by 9-(3'-ethyl phosphonyl-1'-hydroxymethyl-1'-propyloxy-methyl)guanine (1993) (1)
- Utilization of pulse oximetry for study of potential anti-influenza virus compounds in mice (1991) (1)
- PSITTACOSIS COMPLEMENT-FIXING ANTIBODIES IN SERA FROM FAUNA OF THE GREAT SALT LAKE DESERT OF UTAH. (1964) (1)
- Laundering shearling bedpads. (1972) (1)
- Studies on infectious diseases in wild animals in Utah. III. Experimental Q fever in wild vertebrates. (1962) (1)
- Biological Response Modifiers in Combination with Antivirals against Experimentally-Induced Virus Infections (1992) (1)
- POTENTIAL NEW THERAPY FOR INFLUENZA (2002) (1)
- Murine Punta Toro virus infection: a potential model for study of Hantavirusinhibitors (1995) (1)
- Failure of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) to stimllate interferon. (1973) (1)
- New models of murine cytomegalovirus infection in immunocompromised mice (1991) (0)
- Sacrificing for the Lost Cause: General Robert E. Lee's Personal Staff (2018) (0)
- The Decision Was Always My Own: Ulysses S. Grant and the Vicksburg Campaign by Timothy B. Smith (review) (2019) (0)
- Lee and His Generals: Essays in Honor of T. Harry Williams ed. by Lawrence Lee Hewitt and Thomas E. Schott (review) (2014) (0)
- A longitudinal investigation into utilising crosswall construction for multi-storey residential buildings (2009) (0)
- Severity due to Phlebovirus Infection TLR3 Deletion Limits Mortality and Disease (2006) (0)
- 109. Human influenza infection in utero increases SNAP-25 expression in neonatal mice (1998) (0)
- Transgenic mice as models for photo-induced gene expression: activation of human immunodeficiency virus long terminal repeat (1992) (0)
- Is the Anti-Psychotic, 10-(3-(Dimethylamino)propyl)phenothiazine (Promazine), a Dangerous Drug with Which to TreatSARS Infections? Efficacy of Promazine on SARS-CoV Replication in a Mouse Model (2008) (0)
- Use of Disposable Micro Tissue Culture Plates for Antiviral and Interferon Induction Studies (1971) (0)
- Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice (cid:1) (2007) (0)
- SYNTHESIS AND ANTI-DNA VIRUS ACTIVITY OF THE 5′-MONOPHOSPHATE AND THE CYCLIC 3′,5′-MONOPHOSPHATE OF 9-(β-D-XYLOFURANOSYL)GUANINE (1976) (0)
- Utah Science Vol. 45 No. 4, Winter 1984 (2014) (0)
- Contents Vol. 41, 1995 (1995) (0)
- Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 gene. (1999) (0)
- In Vivo Antiviral Activity of 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (1965) (0)
- Lymphocytic Necrosis in Hamsters Inoculated with Western Equine Encephalitis Virus (2007) (0)
- UTAH AGRICULTURAL EXPERIMENT STATION 97 PHOSPHORUS NEEDS OF BEEF CATTLE (2014) (0)
- Recent antiviral chemotherapy publications. (1969) (0)
- Cytopathic Maporal Hantavirus Infection of Vero E6 Cells (2007) (0)
- Effects of a Series of Furine Analogs on Friend Leukemia Virus Infections in Mice 1 (2006) (0)
- Copper Oxide-Based Filters Neutralizing Viruses in Suspensions by (2014) (0)
- MAINTAINING ORDER IN THE MIDST OF CHAOS: ROBERT E. LEE'S USAGE OF HIS PERSONAL STAFF (2009) (0)
- Cyotkines as Potential Therapies for Human Immunodeficiency Virus Infections (1994) (0)
- SYNTHESIS AND ANTIVIRAL AND ENZYMIC STUDIES OF CERTAIN 3-DEAZAGUANINES AND THEIR IMIDAZOLECARBOXAMIDE PRECURSORS (1979) (0)
- Swiss, dba/2, and balb/c mice. (1965) (0)
- Development of Antiviral Drugs against Avian (H5N1) Influenza Virus (2006) (0)
- Self-Contradictions and Morality: A Natural Law Critique of Deliberative Democracy (2007) (0)
- 1-0-D-Ribofuranosyl- 1,2,4-triazole-3-carboxamidine Hydrochloride (1992) (0)
- Synthesis and antitumor and antiviral activities of 1- -D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates. (1972) (0)
- In vitro influenza virus-inhibitory effects of a series of germanium- orsilicon-centered polyoxometalates (1997) (0)
- MultidineTM Augmentation of Natural Killer Cells and Cytolytic T Lymphocytes (1995) (0)
- Development of Methods for Carrier-Mediated Targeted Delivery of Antiviral Compounds Using Monoclonal Antibodies (1987) (0)
- SYNTH. UND VIRUSWIRKUNG VON 4′-HYDROXY-5,6,7,8-TETRAMETHOXYFLAVON (1973) (0)
- Effects of subcutaneous treatments with cidofovir on a vaccinia virus respiratory infection in mice (2003) (0)
- Synthesis of Acyclonucleoside Phosphonates as Antiviral Agents Against Cytomegalovirus. (1995) (0)
- Subject Index Vol. 41, 1995 (1995) (0)
- Treatment of Phlebovirus infections of mice by poly ICLC (1991) (0)
- Cytokines as potential therapies for human immunodeficiency virus infections (2016) (0)
- Effect of Prophylactic Treatment with ASAP-AGX-32 and ASAP Solutions on an Avian Influenza A (H5N1) Virus Infection in Mice (2007) (0)
- In VivoActivation ofHumanImmunodeficiency VirusType1Long Terminal RepeatbyUV TypeA (UV-A)LightplusPsoralen andUV-BLight intheSkinofTransgenic Mice (1991) (0)
- AIDS: Implications to Society and Approaches to Control (1990) (0)
- Acyclic phosphonomethylether nucleosideinhibitors of respiratory viruses (1997) (0)
- Transgenic mice as a chemotherapeutic model for HBV infection (1998) (0)
- Effect ofI-f3-D-Ribofuran osyl-I ,2,4-Triazole.3- Carboxamide (Virazole, ICN1229) on Herpes andVaccinia Keratitis andEncephalitis inLaboratory Animals (1973) (0)
- Subject Index, Vol. 37, 1994 (1994) (0)
- Contents, Vol. 19, 1973 (1973) (0)
- The Grounded Mind: Education and Future Shock. (1974) (0)
- The effects ofhuman cytomegalovirus (HCMV) inhibitory agent, 9-(3'-phosphono-1'-hydroxymethyl-1'-propyloxymethyl)guanine (SR3745), on macromolecular synthesis and in vitro antiviral activityin human diploid cells (1989) (0)
- Acknowledgement to the Reviewers (2005) (0)
- SYNTHESIS AND BIOLOGICAL ACTIVITY OF 9-BETA-D-ARABINOFURANOSYLADENINE CYCLIC 3′,5′-PHOSPHATE AND 9-BETA-D-ARABINOFURANOSYLGUANINE CYCLIC 3′,5′-PHOSPHATE (1974) (0)
- SYNTHESIS AND BIOLOGICAL ACTIVITY OF CERTAIN CARBAMOYL AND ALKOXYCARBONYL DERIVATIVES OF ADENOSINE 3′,5′-CYCLIC PHOSPHATE (1974) (0)
- Practical Synthesis of (−)-Carbocyclic Cytosine (Carbodine) and its In Vitro Antiviral Activity against Venezuelan Equine Encephalitis (VEE) Virus and Yellow Fever Virus (2007) (0)
- Anti-humancytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinonederivatives (1995) (0)
- Contents, Vol. 37, 1994 (1994) (0)
- Procedure fortheEvaluation oftheVirucidal Effectiveness ofan Ethylene OxideGasSterilizer (1969) (0)
- Inhibition ofBluetongue andColorado TickFeverOrbiviruses bySelected Antiviral Substancest (1981) (0)
- N4-beta-d-ribofuranosyltrianzin-3-one-n1-oxide (icn 3520), a new uridine antagonist exhibiting antitumor activity. Abstr. (1973) (0)
- Immunomodulatory Effects of Methionine-Enkephalin in Influenza Infected Mice (1995) (0)
- Determination of the In Vitro and In Vivo Activity of Compounds Tested Against Punta Toro Virus. (1987) (0)
- Inhibition ofMurineHepatitis Virus Infections bythe Immunomodulator 2,3,5,6,7,8-Hexahydro-2-Phenyl-8,8-Dimethoxy- (1987) (0)
- SYNTHESIS AND ANTIVIRAL ACTIVITY OF CERTAIN 5′-MONOPHOSPHATES OF 9-ARABINOFURANOSYLHYPOXANTHINE AND 9-D-ARABINOFURANOSYLHYPOXANTHINE (1975) (0)
- The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection. (1969) (0)
- Procedure for the Evaluation of the Virucidal Effectiveness of an Ethylene Oxide Gas Sterilizer (1969) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert William Sidwell?
Robert William Sidwell is affiliated with the following schools: